Analysis of Profitability Ratios
Profitability ratios measure the company ability to generate profitable sales from its resources (assets).
Profitability Ratios (Summary)
Humana Inc., profitability ratios
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
| Profitability ratio | Description | The company |
|---|---|---|
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Humana Inc. operating profit margin ratio improved from 2021 to 2022 but then slightly deteriorated from 2022 to 2023 not reaching 2021 level. |
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Humana Inc. net profit margin ratio deteriorated from 2021 to 2022 and from 2022 to 2023. |
| Profitability ratio | Description | The company |
|---|---|---|
| ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Humana Inc. ROE improved from 2021 to 2022 but then deteriorated significantly from 2022 to 2023. |
| ROA | A profitability ratio calculated as net income divided by total assets. | Humana Inc. ROA deteriorated from 2021 to 2022 and from 2022 to 2023. |
Operating Profit Margin
Humana Inc., operating profit margin calculation, comparison to benchmarks
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Income from operations | 4,013) | 3,800) | 3,148) | 4,986) | 3,192) | |
| External revenues | 105,305) | 92,488) | 82,877) | 76,001) | 64,387) | |
| Profitability Ratio | ||||||
| Operating profit margin1 | 3.81% | 4.11% | 3.80% | 6.56% | 4.96% | |
| Benchmarks | ||||||
| Operating Profit Margin, Competitors2 | ||||||
| Abbott Laboratories | 16.15% | 19.16% | 19.56% | 15.48% | 14.21% | |
| Cigna Group | 4.40% | 4.69% | 4.60% | 5.12% | 5.31% | |
| CVS Health Corp. | 3.85% | 2.41% | 4.54% | 5.19% | 4.69% | |
| Elevance Health Inc. | 4.47% | 4.94% | 5.15% | 4.97% | 5.49% | |
| Intuitive Surgical Inc. | 24.80% | 25.35% | 31.89% | 24.09% | 30.69% | |
| Medtronic PLC | 17.56% | 18.15% | 14.89% | 16.57% | 20.51% | |
| Shockwave Medical Inc. | 21.79% | 25.35% | -0.37% | -96.86% | -120.76% | |
| UnitedHealth Group Inc. | 8.80% | 8.83% | 8.40% | 8.76% | 8.19% | |
| Operating Profit Margin, Sector | ||||||
| Health Care Equipment & Services | 6.30% | 6.23% | 6.68% | 7.03% | 6.88% | |
| Operating Profit Margin, Industry | ||||||
| Health Care | 9.42% | 13.22% | 13.18% | 10.47% | 12.44% | |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Operating profit margin = 100 × Income from operations ÷ External revenues
= 100 × 4,013 ÷ 105,305 = 3.81%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Humana Inc. operating profit margin ratio improved from 2021 to 2022 but then slightly deteriorated from 2022 to 2023 not reaching 2021 level. |
Net Profit Margin
Humana Inc., net profit margin calculation, comparison to benchmarks
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Net income attributable to Humana | 2,489) | 2,806) | 2,933) | 3,367) | 2,707) | |
| External revenues | 105,305) | 92,488) | 82,877) | 76,001) | 64,387) | |
| Profitability Ratio | ||||||
| Net profit margin1 | 2.36% | 3.03% | 3.54% | 4.43% | 4.20% | |
| Benchmarks | ||||||
| Net Profit Margin, Competitors2 | ||||||
| Abbott Laboratories | 14.27% | 15.88% | 16.42% | 12.99% | 11.56% | |
| Cigna Group | 2.66% | 3.72% | 3.11% | 5.31% | 3.35% | |
| CVS Health Corp. | 2.34% | 1.29% | 2.72% | 2.68% | 2.59% | |
| Elevance Health Inc. | 3.52% | 3.87% | 4.46% | 3.78% | 4.66% | |
| Intuitive Surgical Inc. | 25.24% | 21.25% | 29.85% | 24.33% | 30.80% | |
| Medtronic PLC | 12.03% | 15.90% | 11.97% | 16.56% | 15.16% | |
| Shockwave Medical Inc. | 20.17% | 44.10% | -3.85% | -96.92% | -119.06% | |
| UnitedHealth Group Inc. | 6.09% | 6.25% | 6.06% | 6.03% | 5.76% | |
| Net Profit Margin, Sector | ||||||
| Health Care Equipment & Services | 4.38% | 4.62% | 4.96% | 5.20% | 4.84% | |
| Net Profit Margin, Industry | ||||||
| Health Care | 8.05% | 10.26% | 10.89% | 7.77% | 10.20% | |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Net profit margin = 100 × Net income attributable to Humana ÷ External revenues
= 100 × 2,489 ÷ 105,305 = 2.36%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Humana Inc. net profit margin ratio deteriorated from 2021 to 2022 and from 2022 to 2023. |
Return on Equity (ROE)
Humana Inc., ROE calculation, comparison to benchmarks
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Net income attributable to Humana | 2,489) | 2,806) | 2,933) | 3,367) | 2,707) | |
| Stockholders’ equity | 16,262) | 15,311) | 16,080) | 13,728) | 12,037) | |
| Profitability Ratio | ||||||
| ROE1 | 15.31% | 18.33% | 18.24% | 24.53% | 22.49% | |
| Benchmarks | ||||||
| ROE, Competitors2 | ||||||
| Abbott Laboratories | 14.83% | 18.90% | 19.75% | 13.71% | 11.86% | |
| Cigna Group | 11.17% | 14.86% | 11.39% | 16.81% | 11.26% | |
| CVS Health Corp. | 10.91% | 5.84% | 10.54% | 10.35% | 10.39% | |
| Elevance Health Inc. | 15.23% | 16.59% | 16.93% | 13.77% | 15.15% | |
| Intuitive Surgical Inc. | 13.51% | 11.98% | 14.32% | 10.90% | 16.69% | |
| Medtronic PLC | 7.30% | 9.59% | 7.01% | 9.44% | 9.25% | |
| Shockwave Medical Inc. | 22.03% | 42.24% | -3.78% | -29.11% | -26.53% | |
| UnitedHealth Group Inc. | 25.22% | 25.87% | 24.09% | 23.52% | 24.02% | |
| ROE, Sector | ||||||
| Health Care Equipment & Services | 15.04% | 15.40% | 15.04% | 15.13% | 14.24% | |
| ROE, Industry | ||||||
| Health Care | 18.14% | 22.52% | 23.00% | 16.14% | 21.17% | |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
ROE = 100 × Net income attributable to Humana ÷ Stockholders’ equity
= 100 × 2,489 ÷ 16,262 = 15.31%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Humana Inc. ROE improved from 2021 to 2022 but then deteriorated significantly from 2022 to 2023. |
Return on Assets (ROA)
Humana Inc., ROA calculation, comparison to benchmarks
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Net income attributable to Humana | 2,489) | 2,806) | 2,933) | 3,367) | 2,707) | |
| Total assets | 47,065) | 43,055) | 44,358) | 34,969) | 29,074) | |
| Profitability Ratio | ||||||
| ROA1 | 5.29% | 6.52% | 6.61% | 9.63% | 9.31% | |
| Benchmarks | ||||||
| ROA, Competitors2 | ||||||
| Abbott Laboratories | 7.82% | 9.31% | 9.40% | 6.20% | 5.43% | |
| Cigna Group | 3.38% | 4.63% | 3.46% | 5.44% | 3.28% | |
| CVS Health Corp. | 3.34% | 1.82% | 3.39% | 3.11% | 2.98% | |
| Elevance Health Inc. | 5.50% | 5.86% | 6.26% | 5.28% | 6.21% | |
| Intuitive Surgical Inc. | 11.64% | 10.19% | 12.58% | 9.50% | 14.17% | |
| Medtronic PLC | 4.13% | 5.54% | 3.87% | 5.28% | 5.16% | |
| Shockwave Medical Inc. | 9.40% | 33.43% | -2.64% | -24.15% | -22.04% | |
| UnitedHealth Group Inc. | 8.18% | 8.19% | 8.15% | 7.81% | 7.96% | |
| ROA, Sector | ||||||
| Health Care Equipment & Services | 5.51% | 5.65% | 5.62% | 5.60% | 5.17% | |
| ROA, Industry | ||||||
| Health Care | 6.42% | 8.35% | 8.24% | 5.46% | 7.22% | |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
ROA = 100 × Net income attributable to Humana ÷ Total assets
= 100 × 2,489 ÷ 47,065 = 5.29%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| ROA | A profitability ratio calculated as net income divided by total assets. | Humana Inc. ROA deteriorated from 2021 to 2022 and from 2022 to 2023. |